WBSCR14, a gene mapping to the Williams-Beuren syndrome deleted region, is a new member of the MIx transcription factor network

Human Molecular Genetics

Volumn 10, Issue 6, 2001, Pages 617-627

  Cairo, Stefano ^a   Merla, Giuseppe ^a   Urbinati, Fabrizia ^a,c   Ballabio, Andrea ^a,b   Reymond, Alexandre ^a,d  

^a TELETHON INSTITUTE OF GENETICS AND MEDICINE TIGEM   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; DIMER; DNA; GUANOSINE; HELIX LOOP HELIX PROTEIN; LEUCINE ZIPPER PROTEIN; THYMINE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; BRAIN TISSUE; CELL GROWTH; CONTROLLED STUDY; DIMERIZATION; DNA SEQUENCE; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE MAPPING; GENETIC CODE; GENETIC TRANSCRIPTION; GROWTH REGULATION; HUMAN; HUMAN CELL; INTESTINE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN FAMILY; WILLIAMS BEUREN SYNDROME;

AMINO ACID SEQUENCE; ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 7; DIMERIZATION; DNA; DNA-BINDING PROTEINS; GENE DELETION; GENE EXPRESSION; HUMANS; MICE; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; WILLIAMS SYNDROME;

ANIMALIA;

EID: 0035869117     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Natural history of Williams syndrome: Physical characteristics
2. Bridging cognition, the brain and molecular genetics: Evidence from Williams syndrome
3. The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis
4. Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome
5. Elastin point mutations cause an obstructive vascular disease, supravalvular aortic stenosis
6. Elastin: Genomic structure and point mutations in patients with supravalvular aortic stenosis
7. Williams-Beuren syndrome: Unraveling the mysteries of a microdeletion disorder
8. Williams-Beuren syndrome: Genes and mechanisms
9. Complete physical map of the common deletion region in Williams syndrome and identification and characterization of three novel genes
10. WBSCR14, a putative transcription factor gene deleted in Williams-Beuren syndrome: Complete characterisation of the human gene and the mouse ortholog
11. Binding of myc proteins to canonical and noncanonical DNA sequences
12. Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain
13. Structure and function of the b/HLH/Z domain of USF
14. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: Function and regulation
15. Control of cell proliferation by Myc family genes
16. Cell growth: Downstream of Myc-to grow or to cycle?
17. The role of c-myc in cellular growth control
18. Mysterious liaisons: The relationship between c-Myc and the cell cycle
19. Mechanisms of apoptosis by c-Myc
20. The Myc/Max/Mad network and the transcriptional control of cell behavior
21. Max: A helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc
22. Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity
23. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites
24. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites
25. Mad3 and Mad4: Novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation
26. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif
27. Mlx, a new Max-like bHLHZip family member: The center stage of a novel transcription factors regulatory pathway?
28. MYC oncogenes and human neoplastic disease
29. Repression by the Mad(Mxi1)-Sin3 complex
30. Myc and Max proteins possess distinct transcriptional activities
31. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3
32. An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3
33. Mlx, a novel Max-like BHLHZip protein that interacts with the Max network of transcription factors
34. p16 proteins from melanoma-prone families are deficient in binding to Cdk4
35. c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells
36. Myc and Max associate in vivo
37. Re1B, a new Rel family transcription activator that can interact with p50-NF-kappa B
38. Functional role for c-myc in mitogenic response to platelet-derived growth factor
39. Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation
40. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor
41. Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells
42. Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: Opposite regulation of mad and c-myc
43. Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis
44. Sequential expression of the MAD family of transcriptional repressors during differentiation and development
45. Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor
46. Analysis of Myc/Max/Mad network members in adipogenesis: Inhibition of the proliferative burst and differentiation by ectopically expressed Mad1
47. Mondo A, a novel basic helix-loop-helix-leucine zipper transcriptional activator that constitutes a positive branch of a max-like network
48. Genomic analysis of gene expression in C.elegans
49. Detection of an atypical 7q11.23 deletion in Williams syndrome patients which does not include the STX1A and FZD3 genes
50. Williams syndrome: Use of chromosomal microdeletions as a tool to dissect cognitive and physical phenotypes
51. Genome structure and cognitive map of Williams syndrome
52. Insight into the microphthalmia gene
53. Gene-target recognition among members of the myc super-family and implications for oncogenesis
54. Rapid identification of key amino-acid-DNA contacts through combinatorial peptide synthesis
55. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion
56. Myc target genes
57. Myc and Max homologs in Drosophila
58. Drosophila myc regulates cellular growth during development
59. Evidence for interaction between human PRUNE and nm23-H1 NDPKinase
60. Cooperation between the RING + B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival
61. Expression pattern of the Kallmann syndrome gene in the olfactory system suggests a role in neuronal targeting